 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
With Future of Roche NimbleGen Arrays in Question, Customers Bet on New Platforms
July 17, 2012
With Future of Roche NimbleGen Arrays in Question, Customers Bet on New Platforms
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche to Phase out Chip-Based Sequence Capture; Peptide Arrays 'Close' to Commercialization
October 2, 2012 / BioArray News - Signature Genomics to Adopt Agilent Platform in Light of Roche's Planned Departure from Array Market
July 31, 2012 / BioArray News - Affy, Agilent, Illumina Affirm Commitment to Array Market in Light of Roche's Planned Exit
June 19, 2012 / BioArray News - In Print: Last Month's Microarray Papers of Note
February 7, 2012 / BioArray News - Ambry Genetics, Looking to Entice Pharma, Rolls out CHO Cell Expression Array
January 31, 2012 / BioArray News